P961: CILTACABTAGENE AUTOLEUCEL, A BCMA‐DIRECTED CAR‐T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2‐YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE‐1 STUDY
Lin, Y., Martin, T., Berdeja, J. G., Jakubowiak, A., Agha, M., Cohen, A. D., Deol, A., Htut, M., Lesokhin, A., Munshi, N. C., O'Donnell, E., Jackson, C. C., Yeh, T.‐M., Banerjee, A., Zudaire, E., Madduri, D., Zhou, C., Pacaud, L., Usmani, S. Z., Jagannath, S.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE‐1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE‐CLASS EXPOSED MULTIPLE MYELOMA
Weisel, K., Mateos, M.‐V., Vincent, L., Martin, T., Berdeja, J. G., Jakubowiak, A., Jagannath, S., Lin, Y., Thilakarathne, P., Ghilotti, F., Diels, J., Haefliger, B., Hague, C., Gonzalez, A., Schecter, J. M., Gries, K. S., Strulev, V., Nesheiwat, T., Pacaud, L., Einsele, H., Moreau, P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
S182: TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM MONUMENTAL‐1
Minnema, M. C., Krishnan, A., Berdeja, J. G., Oriol, A., Donk, N. W., Rodríguez‐Otero, P., Morillo, D., Mateos, M.‐V., Costa, L. J., Caers, J., Vishwamitra, D., Ma, J., Yang, S., Hilder, B. W., Tolbert, J., Goldberg, J. D., Chari, A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P10: TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL‐1
Donk, N. W. C. J, Minnema, M C, Berdeja, J G, Oriol, A, Krishnan, A, Rodríguez‐Otero, P, Askari, E, Mateos, M, Costa, L. J, Verona, R, Ma, J, Girgis, S, Yang, S, Hilder, B. W, Russell, J, Goldberg, J. D, Chari, A
Published in HemaSphere (01.04.2022)
Published in HemaSphere (01.04.2022)
Get full text
Journal Article
UPDATED RESULTS FROM THE CARTITUDE-1 STUDY OF CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Usmani, SZ, Berdeja, JG, Jakubowiak, A, Agha, M, Cohen, AD, Madduri, D, Hari, P, Yeh, T, Olyslager, Y, Banerjee, A, Jackson, CC, Allred, A, Zudaire, E, Deraedt, W, Wu, X, Pacaud, L, Akram, M, Lin, Y, Martin, T, Jagannath, S
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D (GPRC5D) CD3 BISPECIFIC ANTIBODY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 STUDY RESULTS
Berdeja, JG, Krishnan, AY, Oriol, A, Donk, NWV, Rodríguez-Otero, P, Askari, E, Mateos, M, Minnema, MC, Costa, LJ, Verona, R, Hilderq, BW, Girgisq, S, Prior, T, Russell, JS, Goldberg, JD, Chari, A
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
B05: RESULTS FROM A META‐ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN'S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Gay, F, Berdeja, JG, De Stefano, V, Hari, P, Hooper, B, Haltner, A, Kumar, S, Martin, T, Mateos, M‐V, Moreau, P, Rosta, E, Samjoo, IA, Usmani, SZ, Weisel, K, Jackson, CC, Olyslager, Y, Schecter, JM, Vogel, M, Garrett, A, Lee, S, Nesheiwat, T, Pacaud, L, Zhou, C, Valluri, S, Costa, LJ, Lin, Y
Published in HemaSphere (01.04.2022)
Published in HemaSphere (01.04.2022)
Get full text
Journal Article
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma
Richardson, Paul G., Trudel, Suzanne, Popat, Rakesh, Mateos, María-Victoria, Vangsted, Annette J., Ramasamy, Karthik, Martinez-Lopez, Joaquín, Quach, Hang, Orlowski, Robert Z., Arnao, Mario, Lonial, Sagar, Karanes, Chatchada, Pawlyn, Charlotte, Kim, Kihyun, Oriol, Albert, Berdeja, Jesus G., Rodríguez Otero, Paula, Casas-Avilés, Ignacio, Spirli, Alessia, Poon, Jennifer, Li, Shaoyi, Gong, Jing, Wong, Lilly, Lamba, Manisha, Pierce, Daniel W., Amatangelo, Michael, Peluso, Teresa, Maciag, Paulo, Katz, Jessica, Pourdehnad, Michael, Bahlis, Nizar J.
Published in The New England journal of medicine (14.09.2023)
Published in The New England journal of medicine (14.09.2023)
Get full text
Journal Article
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
Berdeja, Jesus G, Hart, Lowell L, Mace, Joseph R, Arrowsmith, Edward R, Essell, James H, Owera, Rami S, Hainsworth, John D, Flinn, Ian W
Published in Haematologica (Roma) (01.05.2015)
Published in Haematologica (Roma) (01.05.2015)
Get full text
Journal Article
Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma
Krishnan, A, Kapoor, P, Palmer, J M, Tsai, N-C, Kumar, S, Lonial, S, Htut, M, Karanes, C, Nathwani, N, Rosenzweig, M, Sahebi, F, Somlo, G, Duarte, L, Sanchez, J F, Auclair, D, Forman, S J, Berdeja, J G
Published in Leukemia (18.12.2017)
Published in Leukemia (18.12.2017)
Get full text
Journal Article
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Moreau, Philippe, Kumar, Shaji K, San Miguel, Jesús, Davies, Faith, Zamagni, Elena, Bahlis, Nizar, Ludwig, Heinz, Mikhael, Joseph, Terpos, Evangelos, Schjesvold, Fredrik, Martin, Thomas, Yong, Kwee, Durie, Brian G M, Facon, Thierry, Jurczyszyn, Artur, Sidana, Surbhi, Raje, Noopur, van de Donk, Niels, Lonial, Sagar, Cavo, Michele, Kristinsson, Sigurdur Y, Lentzsch, Suzanne, Hajek, Roman, Anderson, Kenneth C, João, Cristina, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika, Fonseca, Rafael, Vangsted, Annette, Weisel, Katja, Baz, Rachid, Hungria, Vania, Berdeja, Jesus G, Leal da Costa, Fernando, Maiolino, Angelo, Waage, Anders, Vesole, David H, Ocio, Enrique M, Quach, Hang, Driessen, Christoph, Bladé, Joan, Leleu, Xavier, Riva, Eloisa, Bergsagel, Peter Leif, Hou, Jian, Chng, Wee Joo, Mellqvist, Ulf-Henrik, Dytfeld, Dominik, Harousseau, Jean-Luc, Goldschmidt, Hartmut, Laubach, Jacob, Munshi, Nikhil C, Gay, Francesca, Beksac, Meral, Costa, Luciano J, Kaiser, Martin, Hari, Parameswaran, Boccadoro, Mario, Usmani, Saad Z, Zweegman, Sonja, Holstein, Sarah, Sezer, Orhan, Harrison, Simon, Nahi, Hareth, Cook, Gordon, Mateos, Maria-Victoria, Rajkumar, S Vincent, Dimopoulos, Meletios A, Richardson, Paul G
Published in The lancet oncology (01.03.2021)
Published in The lancet oncology (01.03.2021)
Get full text
Journal Article
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Rowinsky, Eric K., Paner, Agne, Berdeja, Jesus G., Paba-Prada, Claudia, Venugopal, Parameswaran, Porkka, Kimmo, Gullbo, Joachim, Linder, Stig, Loskog, Angelica, Richardson, Paul G., Landgren, Ola
Published in Investigational new drugs (01.10.2020)
Published in Investigational new drugs (01.10.2020)
Get full text
Journal Article
Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM)
Berdeja, J. G., Ailawadhi, S., Weitman, S. D., Zildjian, S., O'Leary, J. J., O'Keeffe, J., Guild, R., Whiteman, K., Chanan-Khan, A. A. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results
Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laubach, Jacob P., Stockerl‐Goldstein, Keith E., Kwei, Long, Clow, Fong, Elias, Laurence, Salman, Zeena, Graef, Thorsten, Bilotti, Elizabeth, Vij, Ravi
Published in British journal of haematology (01.03.2018)
Published in British journal of haematology (01.03.2018)
Get full text
Journal Article
Clinical remissions and limited toxicity in a first-in-human multicenter study of bb2121, a novel anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma
Berdeja, J.G, Lin, Y, Raje, N, Siegel, D, Munshi, N, Turka, A, Lam, L.P, Quigley, M.T, Kochenderfer, J.N
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma
Berdeja, Jesüs G., Jones, Richard J., Zahurak, Marianna L., Piantadosi, Steven, Abrams, Ross A., Borowitz, Michael J., Vogelsang, Georgia B., Noga, Stephen J., Ambinder, Richard F., Flinn, Ian W.
Published in Biology of blood and marrow transplantation (01.01.2001)
Published in Biology of blood and marrow transplantation (01.01.2001)
Get full text
Journal Article
Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically
Pitman, Sean D, Huang, Qin, Zuppan, Craig W, Rowsell, Edward H, Cao, Jeffrey D, Berdeja, Jesus G, Weiss, Lawrence M, Wang, Jun
Published in The American journal of surgical pathology (01.04.2006)
Published in The American journal of surgical pathology (01.04.2006)
Get more information
Journal Article